296 related articles for article (PubMed ID: 22929970)
1. Dietary polyphenol-derived protection against neurotoxic β-amyloid protein: from molecular to clinical.
Smid SD; Maag JL; Musgrave IF
Food Funct; 2012 Dec; 3(12):1242-50. PubMed ID: 22929970
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effect of epigallocatechin-3-gallate against beta-amyloid-induced oxidative and nitrosative cell death via augmentation of antioxidant defense capacity.
Kim CY; Lee C; Park GH; Jang JH
Arch Pharm Res; 2009 Jun; 32(6):869-81. PubMed ID: 19557365
[TBL] [Abstract][Full Text] [Related]
3. Novel role of red wine-derived polyphenols in the prevention of Alzheimer's disease dementia and brain pathology: experimental approaches and clinical implications.
Pasinetti GM
Planta Med; 2012 Oct; 78(15):1614-9. PubMed ID: 23023952
[TBL] [Abstract][Full Text] [Related]
4. Structural properties of EGCG-induced, nontoxic Alzheimer's disease Aβ oligomers.
Lopez del Amo JM; Fink U; Dasari M; Grelle G; Wanker EE; Bieschke J; Reif B
J Mol Biol; 2012 Aug; 421(4-5):517-24. PubMed ID: 22300765
[TBL] [Abstract][Full Text] [Related]
5. Electroanalysis of the interaction between (-)-epigallocatechin-3-gallate (EGCG) and amyloid-β in the presence of copper.
Zhang B; Cheng XR; da Silva IS; Hung VW; Veloso AJ; Angnes L; Kerman K
Metallomics; 2013 Mar; 5(3):259-64. PubMed ID: 23443273
[TBL] [Abstract][Full Text] [Related]
6. [Review on the neuroprotective effects of green tea polyphenols for the treatment of neurodegenerative diseases].
Li Q; Li Y
Wei Sheng Yan Jiu; 2010 Jan; 39(1):123-6. PubMed ID: 20364607
[TBL] [Abstract][Full Text] [Related]
7. Aggregation of Aβ(17-36) in the Presence of Naturally Occurring Phenolic Inhibitors Using Coarse-Grained Simulations.
Wang Y; Latshaw DC; Hall CK
J Mol Biol; 2017 Dec; 429(24):3893-3908. PubMed ID: 29031698
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effects of green and black teas and their catechin gallate esters against beta-amyloid-induced toxicity.
Bastianetto S; Yao ZX; Papadopoulos V; Quirion R
Eur J Neurosci; 2006 Jan; 23(1):55-64. PubMed ID: 16420415
[TBL] [Abstract][Full Text] [Related]
9. Neurological mechanisms of green tea polyphenols in Alzheimer's and Parkinson's diseases.
Weinreb O; Mandel S; Amit T; Youdim MB
J Nutr Biochem; 2004 Sep; 15(9):506-16. PubMed ID: 15350981
[TBL] [Abstract][Full Text] [Related]
10. Naturally occurring phytochemicals for the prevention of Alzheimer's disease.
Kim J; Lee HJ; Lee KW
J Neurochem; 2010 Mar; 112(6):1415-30. PubMed ID: 20050972
[TBL] [Abstract][Full Text] [Related]
11. Beneficial Effects of Green Tea Catechins on Neurodegenerative Diseases.
Pervin M; Unno K; Ohishi T; Tanabe H; Miyoshi N; Nakamura Y
Molecules; 2018 May; 23(6):. PubMed ID: 29843466
[TBL] [Abstract][Full Text] [Related]
12. A novel approach of proteomics and transcriptomics to study the mechanism of action of the antioxidant-iron chelator green tea polyphenol (-)-epigallocatechin-3-gallate.
Weinreb O; Amit T; Youdim MB
Free Radic Biol Med; 2007 Aug; 43(4):546-56. PubMed ID: 17640565
[TBL] [Abstract][Full Text] [Related]
13. Surface plasmon resonance imaging of amyloid-β aggregation kinetics in the presence of epigallocatechin gallate and metals.
Cheng XR; Hau BY; Veloso AJ; Martic S; Kraatz HB; Kerman K
Anal Chem; 2013 Feb; 85(4):2049-55. PubMed ID: 23276205
[TBL] [Abstract][Full Text] [Related]
14. Black tea theaflavins inhibit formation of toxic amyloid-β and α-synuclein fibrils.
Grelle G; Otto A; Lorenz M; Frank RF; Wanker EE; Bieschke J
Biochemistry; 2011 Dec; 50(49):10624-36. PubMed ID: 22054421
[TBL] [Abstract][Full Text] [Related]
15. Neurorescue activity, APP regulation and amyloid-beta peptide reduction by novel multi-functional brain permeable iron- chelating- antioxidants, M-30 and green tea polyphenol, EGCG.
Avramovich-Tirosh Y; Reznichenko L; Mit T; Zheng H; Fridkin M; Weinreb O; Mandel S; Youdim MB
Curr Alzheimer Res; 2007 Sep; 4(4):403-11. PubMed ID: 17908043
[TBL] [Abstract][Full Text] [Related]
16. Natural Polyphenols in the Treatment of Alzheimer's Disease.
Syarifah-Noratiqah SB; Naina-Mohamed I; Zulfarina MS; Qodriyah HMS
Curr Drug Targets; 2018; 19(8):927-937. PubMed ID: 28356027
[TBL] [Abstract][Full Text] [Related]
17. (-)-epigallocatechin-3-gallate (EGCG) maintains kappa-casein in its pre-fibrillar state without redirecting its aggregation pathway.
Hudson SA; Ecroyd H; Dehle FC; Musgrave IF; Carver JA
J Mol Biol; 2009 Sep; 392(3):689-700. PubMed ID: 19616561
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Aβ aggregates in Alzheimer's disease by epigallocatechin and epicatechin-3-gallate from green tea.
Chen T; Yang Y; Zhu S; Lu Y; Zhu L; Wang Y; Wang X
Bioorg Chem; 2020 Dec; 105():104382. PubMed ID: 33137558
[TBL] [Abstract][Full Text] [Related]
19. Green tea epigallocatechin-3-gallate (EGCG) and other flavonoids reduce Alzheimer's amyloid-induced mitochondrial dysfunction.
Dragicevic N; Smith A; Lin X; Yuan F; Copes N; Delic V; Tan J; Cao C; Shytle RD; Bradshaw PC
J Alzheimers Dis; 2011; 26(3):507-21. PubMed ID: 21694462
[TBL] [Abstract][Full Text] [Related]
20. A cellular lipidomic study on the Aβ-induced neurotoxicity and neuroprotective effects of EGCG by using UPLC/MS-based glycerolipids profiling and multivariate analysis.
Zhang H; Wang JR; Yau LF; Ho HM; Chan CL; Hu P; Liu L; Jiang ZH
Mol Biosyst; 2012 Oct; 8(12):3208-15. PubMed ID: 23032920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
